Webinar - SGLT2is: Putting the evidence and guidelines into practice
This is a promotional meeting supported and funded by A.Menarini Farmaceutica Internazionale SRL
Webinar Details
This is a promotional meeting supported and funded by A.Menarini Farmaceutica Internazionale SRL including honoraria in accordance with the ABPI code of practice. This meeting is for UK registered HCPs only. This is your personal invitation, please do not share.
Webinar: SGLT2is: Putting the evidence and guidelines into practice
Date: Wednesday 21st May 2025
Time: 1-2pm
Key takeaways
- Introducing the Improving Diabetes Committee Tools
- Implementing the tools to support best practice in prescribing SGLT2is in primary care
- How to access resources
Chair
Helen Kilminster, PCPA Vice President, Senior Clinical Pharmacist - Care Homes PCN Lead & Deputy PCN Clinical Director Citrus Health PCN
Speaker
Philip Newland Jones, Consultant Pharmacist for Diabetes and Endocrinology, University Hospital Southampton NHS FT
Speaker
Philip Newland Jones
Philip Newland-Jones is a Consultant Pharmacist in Diabetes and Endocrinology and is the Clinical Director of the Diabetes and Endocrine service at University Hospitals Southampton NHS Foundation Trust. He is a member of the UKCPA Diabetes and Endocrinology Committee, the Joint British Diabetes Societies (JBDS-IP) Committee, and the Centre of Perioperative Care (CPOC) diabetes working group. He is also currently part of the “Defining the Future of Endocrinology” working group for the Society for Endocrinology.
April 25 | PP-ENDO-UK-0552
